UK and Ireland dates
USA and Canada dates
Australia and NZ dates
Rest Of World dates
Featured Testimonials
THOR on Facebook
THOR on Twitter
THOR on LinkedIn
THOR on Instagram
THOR on YouTubeCategories
Essays
Links
Author Archives: James Carroll
Low-level laser therapy for preventing or treating oral mucositis caused by radiotherapy or chemotherapy
RESULT: After three presentations and much correspondence over a 5 year period we have a recommendation guideline from the National Institute of Health and Care Excellence (NICE) — LLLT for preventing or treating oral mucositis caused by radiotherapy or chemotherapy. This means the NHS can start using our treatment on cancer patients to reduce some of the painful side effects of cancer treatments.
Read here: https://www.nice.org.uk/guidance/ipg615
Posted in Industry
on Low-level laser therapy for preventing or treating oral mucositis caused by radiotherapy or chemotherapy
LumiThera Presents LIGHTSITE I Dry AMD Top Line Final Data
The LIGHTSITE I data was presented at the 2018 Association for Research in Vision and Ophthalmology (ARVO) annual conference by Marion Munk, MD, PhD, Department of Ophthalmology/Bern Photographic Reading Center and Managing Director, Bern Photographic Reading Center, University Hospital Bern. Dr. Munk was part of the investigator team.
“LumiThera PBM treatment demonstrated reductions in central drusen volume over the course of the one-year study versus the sham treatment with statistical significance at one year, (p = 0.05). Drusen is the hallmark pathology of dry AMD and is an important proinflammatory mediator and marker for disease progression,” says Dr. Munk.
“Results from the LIGHTSITE I study following treatment with a multi-wavelength PBM treatment demonstrated clinical improvements in vision outcome measures providing a strong foundation for initial therapy as well as the need for follow-up maintenance therapy,” stated Samuel Markowitz, M.D., Co-Principal Investigator, Department of Ophthalmology and Vision Sciences, University of Toronto. … Continue reading
Posted in Industry
on LumiThera Presents LIGHTSITE I Dry AMD Top Line Final Data
LumiThera Named Most Innovative And Promising Medtech & E-Health Company At Biovision 2017
LumiThera® Inc., a clinical stage medical device company focused on delivering non-invasive photobiomodulation (PBM) therapies for ocular disorders and disease, today announced it has been awarded the prestigious “MOST INNOVATIVE AND PROMISING MEDTECH & E-HEALTH COMPANY” during Biovision 2017 in Lyon, France.
This is great news for patients suffering from dry AMD who have no other treatment alternatives!
Read the full press release:
LumiThera Named Most Innovative And Promising Medtech & E-Health Company At Biovision 2017
Disclosure: I am an investor in Lumithera a) because it successfully treats an unmet medical need, (dry AMD) b) I think it will be the first billion dollar photobiomodulation company.
Posted in Industry
on LumiThera Named Most Innovative And Promising Medtech & E-Health Company At Biovision 2017
The story of how LLLT / Photobiomodulation was discovered
This is an extraordinary lecture. It is the story of how LLLT / Photobiomodulation was discovered, and because of the context in which it occurred you might also find it very moving, so get some tissues. It is an hour and 10 minutes long so get comfortable, maybe get some popcorn and a drink too. I will paste the email that Andrew Mester wrote into the comments section below.
Here is the email from Andrew Mester :
I had the privilege to give a keynote presentation at the most recent NAALT (North American Association of PhotobiomoduLation Therapy) meeting in February 5, 2017 in Coronado Island, San Diego. The title of paper was: “Invention of Laser Biostimulation”. My lecture is in Youtube now.
BACKGROUND:
Photo-medicine is an exciting new field in both scientific and clinical research all over the world and most recently in the USA. I learned in this interesting … Continue reading
Posted in Conference, Interviews, Special Feature
on The story of how LLLT / Photobiomodulation was discovered
LLLT / Photobiomodulation cures acute thrombocytopenia in mice
Zhang et al showed that whole body 810nm laser 100mW/cm2, 30J/cm2 cures acute thrombocytopenia in mice.
Thrombocytopenia is a common hematologic disorder that is managed primarily by platelet transfusions. They showed that noninvasive whole-body illumination cures acute thrombocytopenia triggered by g-irradiation within 2 weeks in mice, as opposed to a 5-week recovery time required in controls.
The low-level laser (LLL) also greatly accelerated platelet regeneration in the presence of anti-CD41 antibody that binds and depletes platelets, and prevented a severe drop in platelet count caused by a common chemo-therapeutic drug.
They conclude: this safe, drug-free, donor-independent modality represents a paradigm shift in the prophylaxis and treatment of thrombocytopenia.
Full abstract and paper here http://stm.sciencemag.org/content/8/349/349ra101
As you know we are investigating the many possible benefits of whole body treatment PBM with our NovoTHOR light pod novoTHOR.com
Posted in Research
on LLLT / Photobiomodulation cures acute thrombocytopenia in mice
New Book: The Truth About Chronic Pain Treatments
The Best and Worst Strategies for Becoming Pain Free
A well researched and unbiased book/resource by Cindy Perlin for people in chronic pain that are not getting adequate relief from their treatment. The book is evidence-based and examines 14 different categories of treatment (including Photobiomodulation – LLLT).
The Truth About Chronic Pain Treatments reviews the evidence for the safety and effectiveness of a wide variety of treatments, and reveals how organized medicine may be keeping you from getting the care you need and deserve.
This comprehensive guide will help you avoid the treatments that don’t work or are likely to cause harm and select the therapies that are most likely to promote healing.
Posted in Books and Journals
on New Book: The Truth About Chronic Pain Treatments
Laser Treatment Halts Oral Mucositis in Its Tracks
Published article by Fran Lowry on Medscape. May 01, 2015.
Spa-like treatment with a cool, low-level laser, similar to that use for wrinkles, vanquishes oral mucositis, one of the most debilitating toxicities of cancer therapy.
“I have been an oncology nurse for over 25 years, and in those 25 years, there has been nothing that helps prevent or is effective against the treatment for oral mucositis, until now,” said Annette Quinn, RN, MSN, from the University of Pittsburgh Cancer Institute.
“Patients say they rank it higher than nausea and vomiting when it comes to adverse side effects, especially because we have good medications to control nausea and vomiting. But the low-level laser works better than we could have hoped,” Quinn told Medscape Medical News.
Read full article from Source: Laser Treatment Halts Oral Mucositis in Its Tracks
(Must be logged in to read, sign up for free Medscape account)
Posted in Research
on Laser Treatment Halts Oral Mucositis in Its Tracks